The patent system in the US and the EU is not rewarding complex research into treatments for a host of prevalent diseases and conditions, and reforms are going in the wrong direction, says Erika Lietzan of the University of Missouri School of Law.
Traditional rivals within the life sciences industry have pledged to cooperate by sharing data, patent libraries, and, if necessary, manufacturing capacity.
We are an international coalition of public policy research institutes and think tanks that believes that the collaboration, open trade and innovation will provide the solutions to the COVID-19 crisis.
They say bullying scars for life, but for one Saudi medical specialist it was early inspiration for a ground-breaking innovation at the sharp end of cartilage reconstruction.
With around a third of the world’s population in lockdown, humanity desperately needs new treatments to turn the tide against COVID-19.
Despite the important role of intellectual property rights in incentivizing innovation, the patenting of pharmaceutical innovation is frequently accused of impeding access to medicine.
We don’t want to die poor: that’s how creatives feel about pending copyright changes Artists, writers and musicians stand to lose significant income if laws are changed, while Big Tech will be the big winner
The WHO is most effective when it unites nations around practical solutions, rather than dividing them in ideological debates. Next week in Geneva the Executive Board needs to steady the ship. WHO’s proper role should to be to set the top priorities for global health, and not try to be all things to all people. WHO must get back to basics, and put politics to one side.
This post is one of a series in the #Innovate4Health policy research initiative. For centuries, people have been fascinated with and assisted by wearable technology.